IPO UPDATE: Biotech gearing up for a big July?
This article was originally published in Scrip
Executive Summary
If 10 drug development firms launched initial public offerings in the US during June and only two biotechnology companies have priced IPOs this month as of 17 July, does that mean the bubble will soon burst and let the air out of the biotech IPO market?